Findings published in the New England Journal of Medicine add support and new insight to the high level of protection
Continue reading »
Home ยป
Trial results show two medications most effective in lowering blood glucose levels in type 2 diabetes patients
Two medications have proven to be most effective in keeping blood glucose levels within a target range while managing type
Continue reading »
Russia to trial ‘light’ one-dose version of Sputnik jab
Russia will trial a one-dose version of its Sputnik V coronavirus vaccine, officials said on Monday, as they aim to
Continue reading »
Superior outcomes for acute myeloid leukemia patients in clinical trial
Patients participating in The Leukemia & Lymphoma Society’s (LLS) groundbreaking precision medicine Beat AML Master Clinical Trial had superior outcomes
Continue reading »
Anti-siglec-8 antibody trial shows promise for treating eosinophilic gastritis and duodenitis
Eosinophilic gastritis and duodenitis are inflammatory diseases characterized by high levels of eosinophils and mast cells (immune system cells) in
Continue reading »
Sanofi and GSK Initiate Phase 1/2 Clinical Trial of COVID-19 Adjuvanted Recombinant Protein-Based Vaccine Candidate
London, UK and Paris, France 03 September 2020 — Sanofi and GSK announce today the start of the Phase 1/2
Continue reading »
Experimental virus drug remdesivir failed in human trial: reports
The experimental antiviral drug remdesivir has failed in its first randomized clinical trial to treat the COVID-19 illness, reports said
Continue reading »
Clinical trial launches to evaluate antimalarial drugs for COVID-19 treatment
Washington University School of Medicine in St. Louis is launching a clinical trial for patients hospitalized with COVID-19 at Barnes-Jewish
Continue reading »
UM to research new aneurysm stent in upcoming multicenter trial
Robert M. Starke, M.D., M.Sc., an experienced neurosurgeon and researcher with the University of Miami Health System and Miller School
Continue reading »
Trial suggests inducing labor over ‘wait and see’ approach for late term pregnancies
Inducing labour at 41 weeks in low risk pregnancies is associated with a lower risk of newborn death compared with
Continue reading »